<DOC>
	<DOCNO>NCT00835198</DOCNO>
	<brief_summary>A 12-week evaluation safety efficacy dapsone gel 5 % use tretinoin gel 0.025 % compare tretinoin gel 0.025 % monotherapy treat moderate severe facial acne vulgaris</brief_summary>
	<brief_title>Dapsone Gel 5 % Tretinoin Gel 0.025 % Versus Tretinoin Gel 0.025 % Monotherapy Facial Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<mesh_term>Dapsone</mesh_term>
	<criteria>Facial acne vulgaris characterize follow : 30100 facial inflammatory lesion ; , 25100 facial noninflammatory lesion ; Stable disease , nonrapidly regress facial acne vulgaris ; , less equal 3 nodule and/or cyst ( diameter great equal 1cm ) Female subject childbearing potential must negative pregnancy test baseline practice reliable method contraception throughout study Noncompliance washout period ; History clinically significant anemia hemolysis ; Skin disease/disorder might interfere diagnosis evaluation acne vulgaris ; Allergy sensitivity component test medication</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>